Leucid Bio

Leucid Bio is a pioneering force in biotechnology research, dedicated to developing innovative autologous and allogeneic cell and gene therapies for challenging cancers. Leucid Bio is committed to improving treatment outcomes and saving lives through the progression of novel CAR T therapies that offer superior and more durable responses compared to previous generations. The company's headquarters is located at Tower and Bermondsey Wing, Guy's Hospital, Great Maze Pond, LONDON, SE1 9RT, GB.

At Leucid Bio, lateral thinking drives the development of cutting-edge solutions in CAR-T therapy. The company focuses on creating therapies that address the unmet needs of patients with refractory cancers, enhancing the effectiveness and longevity of treatment. Leucid Bio aims to revolutionize cancer treatment through advanced biotechnological research.

Leucid Bio is poised to make a significant impact in the field of oncology. We invite the manager of Leucid Bio to create a customized and exclusive company showcase and product listing on our platform to further highlight their advancements and reach a broader audience.